Calidi Biotherapeutics CLDI Q2 2025 earnings
Reported August 8, 2025 · Before market open
EPS-$1.99Miss by $0.07
EPS estimate-$1.92
Next report
Aug 18, 2026 (In 2 weeks)Versus estimates
Revenue
Diluted EPS
Ask the moment Calidi Biotherapeutics reports.
Connect your AI and ask the moment the filing drops. It reads the release, surfaces what management said, and gives you its own read.
Connect your AI
Claude
Questions, answered.
- When did Calidi Biotherapeutics report Q2 2025 earnings?
- Calidi Biotherapeutics (CLDI) reported Q2 2025 earnings on August 8, 2025 before market open.
- What were Calidi Biotherapeutics's Q2 2025 revenue and EPS?
- Calidi Biotherapeutics reported eps of $-1.99 for Q2 2025.
- Did Calidi Biotherapeutics beat estimates in Q2 2025?
- EPS missed the consensus estimate of $-1.92 by $0.07.
- How did Calidi Biotherapeutics's Q2 2025 results compare year-over-year?
- Compared to the same quarter a year prior, eps grew 88.2% from $-16.81.
- Where can I find Calidi Biotherapeutics's Q2 2025 SEC filings?
- You can read the 10-Q periodic report (0001641172-25-022797) directly on SEC EDGAR. The filing index links above go to sec.gov.